© 2025 MergersCorp M&A International.
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.
The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.
They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.
The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.
Research
Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.
Studies
Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.
Biotechnology
The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.
Team
The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.
Market: 65% India / 35% Rest of the World / Europe
Products: 25 OEM Products / Pharma Active Ingredients Raw Material
Most Sold: Antibiotics
Standards: ISO9001, EU Standards (No FDA)
Growth Rate: 20%+ / Year
Size: 100+ Employees
Management: Chemical Engineer Background
Financial: $25M Revenue / $3M EBITDA
Customers:
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This website is operated by MergersUS Inc a US Corporation with registered office at
Notifications
Description
The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.
The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.
They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.
The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.
Research
Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.
Studies
Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.
Biotechnology
The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.
Team
The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.
Market: 65% India / 35% Rest of the World / Europe
Products: 25 OEM Products / Pharma Active Ingredients Raw Material
Most Sold: Antibiotics
Standards: ISO9001, EU Standards (No FDA)
Growth Rate: 20%+ / Year
Size: 100+ Employees
Management: Chemical Engineer Background
Financial: $25M Revenue / $3M EBITDA
Customers:
Basic Details
Target Price:
$40,000,000
Gross Revenue
$25,000,000
EBITDA
$3,000,000
Business ID:
L#20210013
Country
India
City:
Vadodara
Detail
Similar Businesses
Published on December 13, 2022 at 2:46 pm. Updated on December 2, 2023 at 10:35 pm
50-Year-Old Italian Automotive Manufacturing Business of Vehicle Bodies and Trailers
€12,500,000
Manufacturing
Profitable Knitwear Business with Western Customers
$3,750,000
Manufacturing
Tool Box Manufacturing Business
€7,000,000
Manufacturing
20-Year Old Pharmaceutical South American Brand
$11,500,000
Manufacturing, Pharma
American Apparel Manufacturing Business
$3,700,000
Manufacturing
Manufacturer of Aluminum Profile
$60,000,000
Manufacturing
PREVIOUS PROPERTY
Premium Coal Mining Business
NEXT PROPERTY
Russian Intermodal Logistics Terminal